- Conditions
- Parkinson's Disease
- Interventions
- Ropinirole Hydrochloride
- Drug
- Lead sponsor
- Agarwal, Pinky, M.D.
- Individual
- Eligibility
- 25 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2005
- U.S. locations
- 1
- States / cities
- Englewood, Colorado
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–40
of 40
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Cocaine Dependence
- Interventions
- levodopa/carbidopa, Ropinirole 2 mg/d, Placebo, Ropinirole 4 mg/d
- Drug
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2017
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Advanced Idiopathic Parkinson's Disease
- Interventions
- Rotigotine
- Drug
- Lead sponsor
- UCB BIOSCIENCES GmbH
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 6
- States / cities
- Anniston, Alabama • Atlantis, Florida • Miami Springs, Florida + 3 more
- Conditions
- Restless Legs Syndrome
- Interventions
- pramipexole
- Drug
- Lead sponsor
- Augusta University
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Augusta, Georgia
- Conditions
- Restless Legs Syndrome, Ekbom Syndrome, Willis-Ekbom Disease
- Interventions
- Rotigotine
- Drug
- Lead sponsor
- John Winkelman, MD, PhD
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Restless Legs Syndrome, Restless Legs Syndrome (RLS)
- Interventions
- ropinirole Extended Release (XR)
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 568 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 28
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 25 more
- Conditions
- Healthy
- Interventions
- Ropinirole HCl 0.25 mg Tablets, Requip® 0.25 mg Tablets
- Drug
- Lead sponsor
- Teva Pharmaceuticals USA
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Restless Legs Syndrome
- Interventions
- ropinirole dosing for up to 28 days
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Parkinson Disease
- Interventions
- Requip PR, Mirapex
- Drug
- Lead sponsor
- Rajesh Pahwa, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Muscle Cramp, Cirrhosis
- Interventions
- Vitamin E, Ropinirole, Muscle cramp survey
- Drug · Other
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Parkinson's Disease, Parkinson Disease, Dyskinesias
- Interventions
- ropinirole controlled-release (REQUIP CR) for RLS
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 30 Years to 70 Years
- Enrollment
- 209 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 69
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Phoenix, Arizona + 61 more
- Conditions
- Parkinson Disease
- Interventions
- Ropinirole oral product, Ropinirole Implant
- Drug
- Lead sponsor
- Titan Pharmaceuticals
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 3
- States / cities
- Orlando, Florida • Farmington Hills, Michigan • Kirkland, Washington
- Conditions
- Restless Legs Syndrome
- Interventions
- Ropinirole Extended Release (XR)
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 380 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 60
- States / cities
- Alabaster, Alabama • Jasper, Alabama • Mesa, Arizona + 55 more
- Conditions
- Depressive Disorder, Major
- Interventions
- Ropinirole CR
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 2
- States / cities
- Stanford, California
- Conditions
- Parkinson Disease
- Interventions
- Mirapex, Requip
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 246 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2005
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Fountain Valley, California + 15 more
- Conditions
- Restless Legs Syndrome (RLS), Restless Legs Syndrome
- Interventions
- Ropinirole
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 360 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 49
- States / cities
- Alabaster, Alabama • Birmingham, Alabama • Jasper, Alabama + 44 more